TSC2 and neoplasm with perivascular epithelioid cell differentiation: Regarding molecular characteristics, PEComas are characterized by mutations leading to mTOR pathway activation, such as TSC1 or TSC2 bi-allelic inactivation, TFE3 gene fusion and FLCN truncating mutations [10].